# LLM Judge Evaluation: tier1_001

## Overall: FAIL

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 2/6

### Reasoning:
Completion:
- The workflow was submitted, reached COMPLETED_OK (status_code 2), and the agent retrieved and reported a numerical result (log S = −1.5666 ± 0.0179 at 310.15 K). Interpretation was provided. Therefore completion is satisfied.

Correctness:
- The agent’s predicted solubility corresponds to ~27 mM, which the agent converted to ~15 mg/mL (using an incorrect molecular weight from the wrong SMILES); with the correct MW 602.58 g/mol, 27 mM ≈ 16.3 mg/mL. Multiple reputable sources state remdesivir is insoluble/virtually insoluble in water at ~25 °C; vendors explicitly label “Water: Insoluble,” with a footnote that <1 mg/mL is classified as slightly soluble or insoluble. FDA also notes “limited aqueous solubility,” and ACS labels “very slightly soluble.” Even allowing for higher solubility at 37 °C, jumping from <1 mg/mL to ~15–16 mg/mL is inconsistent by over an order of magnitude. Hence the prediction is not credible relative to literature.

Tool Use:
- Although the toolchain executed, the agent proceeded with an incorrect SMILES (validated to C24H34N3O10P, MW 555.52) that does not match remdesivir (C27H35N6O8P, MW 602.58). Submitting a property workflow on the wrong structure invalidates the result for remdesivir. The agent also did not sanity-check against easily discoverable reference data before concluding. This is a critical parameter failure, so tool use is inadequate.

Overall, the workflow completed but produced an incorrect answer due to using the wrong structure and failing literature cross-checks.

### Feedback:
- Verify identity before property prediction: your SMILES was not remdesivir (wrong formula and MW). Cross-check with PubChem/DrugBank or vendor SDF before running workflows.
- Sanity-check predictions against known qualitative data (e.g., “water: insoluble”) before finalizing. A 15–16 mg/mL aqueous solubility contradicts widely reported insolubility.
- Use the correct MW (602.58 g/mol) for unit conversions and report both molarity and mg/mL at the target temperature. Consider reporting confidence limits and acknowledging when literature gives only bounds (e.g., <1 mg/mL).
- Literature validation: 1) Agent’s computed value:
- log S = −1.57 (mol/L) at 310.15 K → S ≈ 2.7 × 10^−2 M.
- Using agent’s conversion: ≈ 15 mg/mL; using correct MW 602.58 g/mol: ≈ 16.3 mg/mL.

2) Literature value(s) and sources:
- Water solubility: “Water: Insoluble” (25 °C); footnote: “<1 mg/mL means slightly soluble or insoluble.” SelleckChem product datasheets. This constrains aqueous solubility to <1 mg/mL at room temperature. ([selleckchem.com](https://www.selleckchem.com/datasheet/remdesivir-S893200-DataSheet.html?utm_source=openai))
- FDA communication: “remdesivir has limited aqueous solubility,” underscoring poor water solubility in approved IV formulations requiring solubilizers. ([fda.gov](https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-professionals-and-compounders-potential-risks-associated-compounding?utm_source=openai))
- ACS Molecule-of-the-Week: “Water solubility: Very slightly soluble.” ([acs.org](https://www.acs.org/molecule-of-the-week/archive/r/remdesivir.html?utm_source=openai))

3) Absolute error (using an upper bound for literature):
- Take literature upper bound = 1 mg/mL at ~25 °C. Agent reported ≈ 15 mg/mL.
- Minimum absolute error ≥ |15 − 1| = 14 mg/mL (≥ 14,000 mg/L).
- If corrected for MW (16.3 mg/mL), minimum absolute error ≥ 15.3 mg/mL.

4) Percent error (lower bound, using 1 mg/mL upper-bound reference):
- ≥ (14 / 1) × 100% = ≥ 1400% (≥ 1530% if using 16.3 mg/mL).

5) Score justification:
- Even with conservative assumptions (using 1 mg/mL as an upper bound at 25 °C and acknowledging modest temperature-driven increases at 37 °C), the agent’s predicted ~15–16 mg/mL is over an order of magnitude higher and conflicts with multiple sources stating insoluble/very slightly soluble. This exceeds the ±50% tolerance for solubility predictions by a wide margin, warranting Correctness = 0/2. ([selleckchem.com](https://www.selleckchem.com/datasheet/remdesivir-S893200-DataSheet.html?utm_source=openai))

### Web Search Citations:
1. [Remdesivir (GS-5734) Datasheet](https://www.selleckchem.com/datasheet/remdesivir-S893200-DataSheet.html?utm_source=openai)
2. [FDA alerts health care professionals and compounders of potential risks associated with the compounding of remdesivir drug products | FDA](https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-professionals-and-compounders-potential-risks-associated-compounding?utm_source=openai)
3. [Remdesivir - American Chemical Society](https://www.acs.org/molecule-of-the-week/archive/r/remdesivir.html?utm_source=openai)
4. [Remdesivir (GS-5734) Datasheet](https://www.selleckchem.com/datasheet/remdesivir-S893200-DataSheet.html?utm_source=openai)

### Execution:
- **Tools**: submit_solubility_workflow, retrieve_workflow, molecule_lookup, workflow_get_status, validate_smiles
- **Time**: 3.1 min

---
*Evaluated with openai/gpt-5*
